Is t(11;14) Always a Standard-Risk Cytogenetic Abnormality? Results From GEM05MENOS65 and GEM2012 PETHEMA/GEM Transplantation Trials
Clin Lymphoma Myeloma Leuk. 2025 Jan 25:S2152-2650(25)00024-2.…
Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib
Cancers (Basel). 2025 Jan 23;17(3):375. doi: 10.3390/cancers17030375.ABSTRACTWe…
The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT
Bone Marrow Transplant. 2025 Feb 12. doi: 10.1038/s41409-025-02524-2.…
Brexucabtagene autoleucel versus allogeneic hematopoietic cell transplantation in relapsed and refractory mantle cell lymphoma
Blood Cancer Discov. 2025 Feb 6. doi: 10.1158/2643-3230.BCD-24-0178.…
KPC pancreatic cancer cells are a novel immunocompetent murine model supporting human adenovirus replication and tumor oncolysis
Mol Ther Oncol. 2024 Dec 21;33(1):200928. doi: 10.1016/j.omton.2024.200928.…
Frailty assessment in adults undergoing allogeneic hematopoietic cell transplantation: insights from a multicenter GETH-TC study to optimize outcomes and care
Front Immunol. 2025 Jan 7;15:1512154. doi: 10.3389/fimmu.2024.1512154.…
Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial
Blood. 2025 Jan 10:blood.2024026830. doi: 10.1182/blood.2024026830.…
Cancer genetic counseling in Chile: Addressing barriers, confronting challenges, and seizing opportunities in an underserved Latin American Community
Genet Med Open. 2024 Oct 30;2(Suppl 2):101898. doi: 10.1016/j.gimo.2024.101898.…
Anti-CD19 CAR T-cell therapy for primary and secondary CNS lymphomas
Bone Marrow Transplant. 2024 Dec 14. doi: 10.1038/s41409-024-02496-9.…
High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience
Hemasphere. 2024 Dec 10;8(12):e70031. doi: 10.1002/hem3.70031.…
Safety and Efficacy of Tinostamustine in a Subpopulation of Patients With Relapsed/Refractory Hodgkin Lymphoma From a Phase I Trial
Hematol Oncol. 2025 Jan;43(1):e70000. doi: 10.1002/hon.70000.ABSTRACTA…
Assessing the Prognostic Value of Cytoplasmic and Stromal Caveolin-1 in Early Triple-Negative Breast Cancer Undergoing Neoadjuvant Chemotherapy
Int J Mol Sci. 2024 Nov 14;25(22):12241. doi: 10.3390/ijms252212241.ABSTRACTTriple-negative…
